ISOMATEX and MBrace, revolutionizing scoliosis treatment with high-performance innovation

Revolutionizing scoliosis treatment with high-performance innovation

When innovative materials meet pediatric care, transformation happens. ISOMATEX and MBrace (www.m-brace.com) have joined forces to reinvent scoliosis treatment – bringing to life a new generation of orthopedic braces that blend clinical performance with comfort, style and sustainability.

At the heart of this innovation is TENRON, ISOMATEX’s advanced fibre, seamlessly integrated into MBrace’s Tailored Fibre Placement (TFP) technology. This combination allows for a precisely engineered, custom-fit brace that redefines both performance and patient experience.

Scoliosis, which predominantly affects adolescents – 80% of whom are girls – is traditionally managed with rigid, uncomfortable braces. These outdated solutions often lead to physical discomfort and emotional distress.

That’s why we’ve developed a brace that does more than just treat – it supports and empowers. TENRON’s unique flexibility, strength, and excellent bonding to matrix materials enable the creation of a lightweight, breathable brace that fits each patient’s body perfectly. The result: enhanced comfort, improved spinal correction, and a design that patients are more willing to wear.

Built to last, this next-gen brace extends its usable life from the typical 3–6 months to an impressive 12–18 months, making it a more durable and eco-conscious solution for modern healthcare.

Thanks to the integration of 3D scanning, AI-driven modeling, and our proprietary high-performance fibre, these braces are less visible under clothing and easier to wear day-to-day. Early clinical trials are already showing positive results: better patient outcomes, higher confidence, and increased social acceptance.

Together, ISOMATEX and MBrace are shaping the future of pediatric orthopedics – one brace at a time.